Nordic Nanovector: European Patent Granted for Betalutin® or Humalutin® in Combination With Anti-CD20 Antibodies for Treating NHL – BioSpace

Nordic Nanovector: European Patent Granted for Betalutin® or Humalutin® in Combination With Anti-CD20 Antibodies for Treating NHL  BioSpace

Published: Jun 03, 2019. OSLO, Norway, June 3, 2019 /PRNewswire/ — Nordic Nanovector ASA (OSE: NANO) announces that the European Patent …